Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-04

Clinical Trial Update: RECOVER-NEURO: Platform Protocol, Appendix_A to Measure the Effects of BrainHQ, PASC CoRE and tDCS Interventions on Long COVID Symptoms [NA]

View source ↗

Summary

A completed trial protocol update for RECOVER-NEURO detailing methods and outcome measures for BrainHQ, PASC CoRE, and tDCS interventions in Long COVID.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Duke University | Conditions: Long COVID, Long Covid19 | NA | Status: COMPLETED